Lianhuan Pharmaceutical announced that the company recently received the “Drug Clinical Trial Approval Notice” approved and issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) for new Midana tablets, and will conduct clinical trials in the near future.
联环药业：咪达那新片获得药物临床试验批准通知书
Lianhuan Pharmaceutical: Midana's new tablet received a notice of approval for clinical trials of the drug
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.